vs
Side-by-side financial comparison of Hilltop Holdings Inc. (HTH) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.
Hilltop Holdings Inc. is the larger business by last-quarter revenue ($300.5M vs $209.6M, roughly 1.4× Varex Imaging Corp). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs 1.1%, a 11.9% gap on every dollar of revenue. Over the past eight quarters, Varex Imaging Corp's revenue compounded faster (0.8% CAGR vs 0.6%).
Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
HTH vs VREX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $300.5M | $209.6M |
| Net Profit | $39.0M | $2.3M |
| Gross Margin | — | 33.3% |
| Operating Margin | — | 7.3% |
| Net Margin | 13.0% | 1.1% |
| Revenue YoY | — | 4.9% |
| Net Profit YoY | -12.4% | 866.7% |
| EPS (diluted) | $0.64 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $300.5M | $209.6M | ||
| Q4 25 | $329.9M | $228.9M | ||
| Q3 25 | $330.2M | $203.0M | ||
| Q2 25 | $303.3M | $212.9M | ||
| Q1 25 | $318.5M | $199.8M | ||
| Q4 24 | $301.1M | — | ||
| Q3 24 | $305.5M | $205.7M | ||
| Q2 24 | $297.0M | $209.1M |
| Q1 26 | $39.0M | $2.3M | ||
| Q4 25 | $41.6M | $12.2M | ||
| Q3 25 | $45.8M | $-89.1M | ||
| Q2 25 | $36.1M | $6.9M | ||
| Q1 25 | $42.1M | $-300.0K | ||
| Q4 24 | $35.5M | — | ||
| Q3 24 | $29.7M | $-51.1M | ||
| Q2 24 | $20.3M | $1.4M |
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 16.1% | 8.6% | ||
| Q3 25 | 18.4% | -39.8% | ||
| Q2 25 | 16.3% | 10.4% | ||
| Q1 25 | 18.1% | 5.6% | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 13.9% | 5.3% | ||
| Q2 24 | 10.0% | 4.4% |
| Q1 26 | 13.0% | 1.1% | ||
| Q4 25 | 12.6% | 5.3% | ||
| Q3 25 | 13.9% | -43.9% | ||
| Q2 25 | 11.9% | 3.2% | ||
| Q1 25 | 13.2% | -0.2% | ||
| Q4 24 | 11.8% | — | ||
| Q3 24 | 9.7% | -24.8% | ||
| Q2 24 | 6.8% | 0.7% |
| Q1 26 | $0.64 | $0.05 | ||
| Q4 25 | $0.68 | $0.29 | ||
| Q3 25 | $0.74 | $-2.15 | ||
| Q2 25 | $0.57 | $0.17 | ||
| Q1 25 | $0.65 | $-0.01 | ||
| Q4 24 | $0.55 | — | ||
| Q3 24 | $0.46 | $-1.25 | ||
| Q2 24 | $0.31 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $125.6M |
| Total DebtLower is stronger | $990.8M | $367.6M |
| Stockholders' EquityBook value | $2.2B | $476.9M |
| Total Assets | $15.7B | $1.1B |
| Debt / EquityLower = less leverage | 0.46× | 0.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $125.6M | ||
| Q4 25 | — | $155.1M | ||
| Q3 25 | — | $152.6M | ||
| Q2 25 | — | $223.0M | ||
| Q1 25 | — | $212.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $200.5M | ||
| Q2 24 | — | $190.0M |
| Q1 26 | $990.8M | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
| Q1 26 | $2.2B | $476.9M | ||
| Q4 25 | $2.2B | $472.6M | ||
| Q3 25 | $2.2B | $455.3M | ||
| Q2 25 | $2.2B | $549.7M | ||
| Q1 25 | $2.2B | $540.2M | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.2B | $529.1M | ||
| Q2 24 | $2.1B | $581.2M |
| Q1 26 | $15.7B | $1.1B | ||
| Q4 25 | $15.8B | $1.1B | ||
| Q3 25 | $15.6B | $1.1B | ||
| Q2 25 | $15.4B | $1.4B | ||
| Q1 25 | $15.8B | $1.3B | ||
| Q4 24 | $16.3B | — | ||
| Q3 24 | $15.9B | $1.2B | ||
| Q2 24 | $15.6B | $1.3B |
| Q1 26 | 0.46× | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-16.1M |
| Free Cash FlowOCF − Capex | — | $-26.8M |
| FCF MarginFCF / Revenue | — | -12.8% |
| Capex IntensityCapex / Revenue | — | 5.1% |
| Cash ConversionOCF / Net Profit | — | -7.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $-38.7M | $7.9M | ||
| Q3 25 | $273.0M | $7.7M | ||
| Q2 25 | $-234.6M | $16.6M | ||
| Q1 25 | $5.8M | $9.5M | ||
| Q4 24 | $273.9M | — | ||
| Q3 24 | $515.6M | $25.9M | ||
| Q2 24 | $-435.3M | $8.0M |
| Q1 26 | — | $-26.8M | ||
| Q4 25 | $-55.5M | $2.3M | ||
| Q3 25 | $271.0M | $1.4M | ||
| Q2 25 | $-234.6M | $9.8M | ||
| Q1 25 | $5.0M | $5.3M | ||
| Q4 24 | $266.8M | — | ||
| Q3 24 | $513.8M | $19.9M | ||
| Q2 24 | $-437.3M | $3.3M |
| Q1 26 | — | -12.8% | ||
| Q4 25 | -16.8% | 1.0% | ||
| Q3 25 | 82.1% | 0.7% | ||
| Q2 25 | -77.4% | 4.6% | ||
| Q1 25 | 1.6% | 2.7% | ||
| Q4 24 | 88.6% | — | ||
| Q3 24 | 168.2% | 9.7% | ||
| Q2 24 | -147.2% | 1.6% |
| Q1 26 | — | 5.1% | ||
| Q4 25 | 5.1% | 2.4% | ||
| Q3 25 | 0.6% | 3.1% | ||
| Q2 25 | 0.0% | 3.2% | ||
| Q1 25 | 0.3% | 2.1% | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 0.6% | 2.9% | ||
| Q2 24 | 0.7% | 2.2% |
| Q1 26 | — | -7.00× | ||
| Q4 25 | -0.93× | 0.65× | ||
| Q3 25 | 5.96× | — | ||
| Q2 25 | -6.50× | 2.41× | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 7.71× | — | ||
| Q3 24 | 17.36× | — | ||
| Q2 24 | -21.41× | 5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HTH
| Noninterest Income | $188.4M | 63% |
| Net Interest Income | $112.1M | 37% |
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
